Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Cystatin E/M Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB1286
This item is not returnable.
View return policy
Description
Cystatin E/M/CST6 Monoclonal specifically detects Cystatin E/M/CST6 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunoprecipitation, Neutralization.Specifications
Cystatin E/M/CST6 | |
Monoclonal | |
LYOPH | |
Western Blot 2 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunoprecipitation 25 ug/mL, Neutralization 7 ug/mL | |
Q15828 | |
CST6 | |
Mouse myeloma cell line NS0-derived recombinant human Cystatin E/M Arg29-Met149 Accession # Q15828 | |
500 μg | |
Primary | |
Detects human Cystatin E/M in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) Cystatins A, B, C, S, SA, SN, rhFetuin A, B, rhHRGP, or rhKininogen is observed. | |
Human | |
Purified |
Western Blot, Immunohistochemistry, Immunoprecipitation, Neutralization | |
211515 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CST6, cystatin 6, cystatin E/M, cystatin M, cystatin M/E, Cystatin-6, Cystatin-E, cystatin-M, cysteine proteinase inhibitor | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
1474 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction